OrqagaIPO Calendar: Upcoming US IPOs
Tickers, price ranges and expected dates for upcoming and recently priced US IPOs — updated weekly
31/07/2026
A running list of upcoming and recently priced US IPOs, updated weekly. Dates, price ranges and deal sizes change frequently ahead of pricing — treat the table below as a snapshot as of September 18, 2026, and confirm details before making any decision.
Upcoming and Recent IPOs
| Company | Ticker | Price Range | Est. Deal Size | Expected Date |
|---|---|---|---|---|
| Electra Therapeutics | ETRA | Priced at $15.00 | $350.0M | Priced 9/18/2026 |
| Orion180 Insurance Group | OIG | Priced at $12.00 (below $15.00–$17.00 range) | $240.0M | Priced 9/18/2026 |
| Leader's Advantage Acquisition Corp. | LEDRU | Priced at $10.00 | $150.0M | Priced 9/18/2026 |
| American Savings Bank of Hawaii | ASBH | Priced at $16.00, first-day close $17.00 | $120.0M | Priced 9/16/2026 |
| Bamboo Insurance Services | BMB | $18.00–$20.00 | $665.0M | 9/23/2026 |
| Amaero (Cross-Listing) | AMRO | $7.06 | $52.7M | 9/23/2026 |
| BW Industrial Holdings | BWGC | $6.00–$7.00 | $17.1M | Week of 9/24/2026 |
| Web3Labs Global | MDAT | $4.00–$5.00 | $28.1M | Week of 9/24/2026 |
| Encore Medical Inc. | EMI | $5.00 | $15.0M | 9/30/2026 |
What to Watch
The IPO market reopened this week after a quiet stretch, with four deals pricing between September 16 and September 18. The headline was Electra Therapeutics (ETRA), a late clinical-stage immunology and oncology biotech, which priced 23.3 million shares at $15.00 — the upper half of its $14–$16 range — to raise roughly $350 million, the largest operating-company deal of the week. Orion180 Insurance Group (OIG), a Melbourne, Florida-based excess-and-surplus homeowners insurer, priced below its marketed $15–$17 range at $12.00, raising $240 million, a sign that investor appetite for smaller insurance names is more selective than for biotech right now. Hawaii's American Savings Bank (ASBH) priced its NYSE listing at $16.00 on September 16 and closed its first day at $17.00, a modest but positive debut for the bank-holding offering. A blank-check vehicle, Leader's Advantage Acquisition Corp. (LEDRU), also priced a $150 million SPAC deal on September 18. Looking ahead, Bamboo Insurance Services (BMB) is on deck for September 23 with an $18–$20 range targeting up to $665 million, which would be the largest deal on the calendar over the next two weeks.
Off the calendar but still dominating headlines: with Anthropic's confidential S-1 still unpublished, pre-IPO speculation has moved into crypto derivatives markets. Perpetual futures tracking Anthropic's eventual public valuation traded on Hyperliquid this week at an implied market cap as high as $2.36 trillion — more than double the $965 billion price set in its May Series H round — even though no Anthropic shares yet exist to trade. Anthropic has also moved to void any unauthorized transfers of its stock ahead of a listing, including through tokenized products or special-purpose vehicles, a detail worth watching for anyone holding synthetic pre-IPO exposure.
Why It Matters for Pre-IPO and Tokenized Equity Investors
This week's mixed results — a strong reception for Electra Therapeutics against a discounted price for Orion180 — are a reminder that public IPO demand can be uneven even in an active week, and that signal feeds into the broader private-to-public pipeline that Pre-IPO and tokenized equity investors track. The Anthropic perpetual futures trading at an implied valuation above $2 trillion show there is real demand for exposure to pre-IPO AI leaders, but Anthropic's own move to void unauthorized token transfers is a pointed reminder that synthetic or tokenized exposure to a private company carries risks a public listing does not, until the underlying shares are actually registered and tradeable. Investors weighing tokenized pre-IPO exposure to Anthropic, OpenAI, or SpaceX should treat derivatives pricing as a sentiment gauge, not a guaranteed path to the eventual IPO price.
This material is for informational purposes only and does not constitute individual investment advice.
Sources
Tojikiston bo'yicha qo'ng'iroqlar uchun
Kompaniya haqida:
Investitsiyalar
Ma'lumot
Taklif etilgan ma'lumot tanishuv xarakteriga ega va chet el valyutasini, qimmatli qog'ozlarni va/yoki boshqa moliya vositalarini sotib olish yoki sotish taklifi sifatida ko'rib chiqilmasligi kerak. Ushbu saytda taklif etilgan ma'lumot shaxsiy investitsion tavsiya hisoblanmaydi. Ushbu bo'limda tilga olingan moliya vositalari yoki operatsiyalar sizga mos kelmasligi, sizning investitsion profilingizga, moliyaviy holatingizga, investitsion tajribangizga, bilimingizga, investitsion maqsadlaringizga, xavf va daromadlilikga munosabatingizga mos kelmasligi mumkin.
«Birjalik Broker» MChJ kelajakda qo'yilmalarning daromadliligiga kafolat bermaydi va va'da bermaydi, mumkin investitsiyalarning ishonchliligiga va mumkin daromadlarning barqaror o'lchamlariga kafolat bermaydi. O'tkandagi investitsiya natijalari kelajakda daromad olishga kafolat hisoblanmaydi.
«Birjalik Broker» MChJ investorning moliya vositalariga operatsiya qilish va investitsiya qilish vaqtida mumkin zararlari uchun javobgar emas, shuningdek qaytarishga, investitsiyalarning samaradorligi va daromadliligiga kafolat bermaydi.
Ushbu bilan «Birjalik Broker» MChJ «Birjalik Broker» MChJ Tojikiston Respublikasi Moliya vazirligidan qimmatli qog'ozlar bozorining kasbiy ishtirokchisining quyidagi litsenziyalariga muvofiq o'z faoliyatini amalga oshirayotganini xabar qiladi: depozitariy faoliyatini amalga oshirishga №010/25 25.06.2025; brokerlik faoliyatini amalga oshirishga №007/25 25.06.2025; dilerlik faoliyatini amalga oshirishga №008/25 25.06.2025 va qimmatli qog'ozlarni boshqarish bo'yicha faoliyatni amalga oshirishga №009/25 25.06.2025, shuningdek manfaatlar to'qnashuvining paydo bo'lish xavfi borligi haqida xabar qiladi, jumladan «Birjalik Broker» MChJ qimmatli qog'ozlar bozorida kasbiy faoliyatni kasbiy faoliyatning turli turlarini birlashtirish shartlari bilan amalga oshirishiga bog'liq.